acrolein has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Dong, L; He, T; Li, L; Li, Y; Wen, Y; Zhang, C; Zhang, X; Zhang, Y; Zhao, J; Zheng, X; Zhu, X | 1 |
Igarashi, K; Ishii, I; Kashiwagi, K; Nishimura, K; Okuyama, S; Omura, T; Saiki, R | 1 |
2 other study(ies) available for acrolein and Cerebral Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia.
Topics: Acrolein; Animals; Anti-Inflammatory Agents; Brain; Chemokine CCL2; Disease Models, Animal; E-Selectin; Infarction, Middle Cerebral Artery; Interleukin-1beta; Male; Mice; Neuroprotective Agents; NF-kappa B; RNA, Messenger; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Water | 2015 |
Intense correlation between brain infarction and protein-conjugated acrolein.
Topics: Acetylcysteine; Acrolein; Animals; Brain; Carrier Proteins; Disease Models, Animal; Down-Regulation; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Photochemistry; Rose Bengal; Spermidine; Spermine; Time Factors; Up-Regulation | 2009 |